U.S. flag An official website of the United States government
  1. Home
  2. Emergency Preparedness and Response
  3. Counterterrorism and Emerging Threats
  4. Medical Countermeasures Initiative (MCMi)
  5. About MCMi
  6. MCMi Program Update
  1. About MCMi

MCMi Program Update

This annual report provides an update on FDA's work to support medical countermeasure-related public health preparedness and response efforts.

MCMi FY21 Program Update report cover


View the latest report (PDF, 1.4 MB)

FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA ensures that medical countermeasures (MCMs)—including drugs, vaccines and diagnostic tests—to counter these threats are safe, effective, and secure.

FDA works closely with interagency partners through the U.S. Department of Health and Human Services (HHS) Public Health Emergency Medical Countermeasures Enterprise (PHEMCE, or Enterprise) to build and sustain the MCM programs necessary to effectively respond to public health emergencies. FDA also works closely with the U.S. Department of Defense (DoD) to facilitate the development and availability of MCMs to support the unique needs of American military personnel.

FDA COVID-19 response through FY 2021 infographic thumbnail

The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), requires FDA to issue an annual report detailing its medical countermeasure activities. This report responds to that requirement for the latest fiscal year available. 

The FY 2021 report includes a snapshot of the Agency's COVID-19 response efforts through September 30, 2021, and a new infographic about FDA's COVID-19 response from the beginning of the COVID-19 public health emergency through the end of FY 2021 (September 30, 2021).   

Related information


Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.

Back to Top